AHNAK2 and small cell lung carcinoma: Additionally, mutations ( >15% frequency) in genes involved in KMT2D, ZFHX3, EP300, AHNAK2, and NOTCH1 had been identified, suggesting potential alternative drivers in SCLC pathogenesis (Supplementary Fig.2a).